Aim Bronchiolitis is a common condition in the paediatric population. Severe cases often
receive respiratory support with high‐flow nasal cannula (HFNC). Significant variation in the …

Aim To determine the prevalence of high flow nasal cannula (HFNC) therapy in infants
presenting to hospital in Australia and New Zealand with bronchiolitis over four bronchiolitis …

Objective The objective was to examine the safety and efficacy of high‐flow nasal cannula
(HFNC) therapy for children with bronchiolitis in a non‐tertiary paediatric setting. Methods …

Aim Using a high‐flow nasal cannula (HFNC) for infant bronchiolitis is increasingly common,
but insufficiently studied. In this retrospective study, we examined the outcomes of HFNC …

Purpose Our aim was to evaluate the impact of the initial high flow nasal cannula (HFNC)
flow rate on clinical outcomes in children with bronchiolitis. Methods This secondary …

Introduction Bronchiolitis is the most common viral lower respiratory tract infection in children
under 2 years of age. Respiratory support with high-flow nasal cannula (HFNC) is …

Background The objective was to determine whether high-flow nasal cannula (HFNC), a
promising respiratory support in infant bronchiolitis, could reduce the proportion of treatment …

Objectives Bronchiolitis is the most common viral lower respiratory tract infection in children
under age 2 for which high-flow nasal cannula (HFNC) is increasingly used. Understanding …

Aim We aimed to describe the characteristics and outcomes of infants with bronchiolitis who
received high‐flow nasal cannula oxygen (HFNC) following a two‐tiered approach. Methods …

Aim High‐flow nasal cannula (HFNC) therapy provides noninvasive respiratory support for
infant bronchiolitis and its use has increased following good clinical experiences. This …